Dana S. Hardin, MD, is a member of the Section of Endocrinology and Metabolism at Nationwide Children’s Hospital and a Professor of Pediatrics in The Ohio State University College of Medicine. She is a principal investigator at the Center for Clinical and Translational Research at The Research Institute at Nationwide Children’s Hospital. Dr. Hardin is board certified by the American Academy of Pediatrics, the American Board of Pediatric Endocrinology and the American Board of Physician Nutrition Specialists. Dr. Hardin obtained her medical degree from Indiana University in 1986, where she then went on to complete her fellowship and residency finishing in 1993. Dr. Hardin has become well known for her research and teaching interests and is a frequently invited speaker nationally and internationally. Clinical and research interests include growth disorders, the chronically ill and diabetes. She has grants, from the National Institute of Health (NIH) and other organizations, for studies on chronic illness. She is the Study Section Chair of the NIH, SBIR/STTR Endocrinology and Metabolism. She is a board member and consultant for a number of professional societies and pharmaceutical companies. In association with the Genetics section at Nationwide Children’s Hospital, she was instrumental in establishing a new Prader Willi Clinic.
Publications*:
Dyer JS, Rosenfeld C, Rice J, Rice M, Hardin DS. Insulin Resistance in Hispanic Large-for-Gestational-Age Neonates at Birth. The Journal of Clinical Endocrinology & Metabolism 92(10): 3836-3843, 2007.
Hardin DS, Kemp SF, Allen DB. Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers. Clinical Pediatrics 46(4): 279-86, 2007.
Hardin DS. A Review of the Management of Two Common Clinical Problems Found in Patients with Cystic Fibrosis: Cystic Fibrosis-Related Diabetes and Poor Growth. Hormone Research 68(S5): 113-116, 2007.
Hardin DS. Controversial debate: growth hormone and glucose metabolism. Hormone Research 67 (supplement) 1:32, 2007.
Hardin DS, Woo J, Butsch R, Huett B. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of pediatric endocrinologists. Clinical Endocrinology 66(1): 85-94, 2007.
Awards and Honors*:
Appointed Chair, NIH, SBIR/STTR Study Division for Endocrinology and Metabolism, 2007-2010
Listed, Best Doctors in America
Listed as one of the Top Pediatricians by the Consumers’ Research Council of America, 2004-2007
Presentations and Teaching Activities*:
Improving Compliance in Diabetes Care, American Association of Diabetes Educators, Louisville, Kentucky, September 2007
Use of Growth Hormone in Adolescents, University of Alabama, Mobile, Alabama, September 2007
Use of Growth Hormone in Adolescents, University of West Florida, Pensacola, Florida, September 2007
Diabetes in Cystic Fibrosis, Pediatric Grand Rounds, University of West Virginia, Morgantown, West Virginia, October 2007
Growth Hormone Use in Cystic Fibrosis, North American Cystic Fibrosis Conference, Anaheim, California, October 2007
Improving Compliance in Diabetes Care, Neo-American Association of Diabetes Educators (AADE), Cleveland, Ohio, October 2007
Nutrition in Cystic Fibrosis, Annual North American Cystic Fibrosis Meeting, Anaheim, California, October 2007
Use of Recombinant IGF-1 in Non-Growth Hormone Deficient Patients, International Committee on IGF-1 Use, San Diego, California, November 2007
Psycho-Social Issues in Diabetes, 2nd International Global Diabetes Summit, Columbus, Ohio, November 29-30, 2007
Research Funding*:
Increased Gluconeogenesis is One Cause of CFRD, National Institute of Diabetes and Digestive and Kidney Diseases
Multi-center study of IGF-1 in Cystic Fibrosis, Tercica
Growth Hormone Registry, Anonymous
Growth Hormone Treatment in Children with Juvenile Rheumatoid Arthritis, Anonymous
*Physician publications, awards and honors, and presentations and teaching activities represent work completed in 2007 only.
